Abstract
BackgroundApremilast (APR), an oral phosphodiesterase 4 inhibitor, works intracellularly to regulate inflammatory mediators. The Work Limitations Questionnaire (WLQ) is a reliable tool for assessing work productivity in patients with chronic...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have